Accuracy of diagnosis on death certificates for underlying causes of death in a long-term autopsy-based population study in Hisayama, Japan; with special reference to cardiovascular diseases

Hasuo, Yutaka; Ueda, Kazuo; Kiyohara, Yutaka; Wada, Junichi; Kawano, Hideo; Kato, Ikunoshin; Yanai, Toshiro; Fuji, Ichiro; Omae, Teruo; Fujishima, Masatoshi

doi:10.1016/0895-4356(89)90154-6

Cited by 90 publications

(49 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Routine mortality statistics are often the only data collected nationwide. Whilst such data can provide an overview of trends and occurrence of stroke, several stroke studies, including European ones, have concluded that the validity of routine mortality stroke data is of varying quality [46][47][48][49][50][51]. Data may be either an over-or under-estimate of the number of stroke deaths compared with standard criteria, which would have effect on the WHO estimates for incidence and prevalence rates because of the methodology described.…”

Section: Stroke Incidence and Prevalence In Europementioning

confidence: 99%

Stroke incidence and prevalence in Europe: a review of available data

Truelsen

Piechowski-Jóźwiak

Bonita

et al. 2006

Euro J of Neurology

545

340

View full text Add to dashboard Cite

Reliable data on stroke incidence and prevalence are essential for calculating the burden of stroke and the planning of prevention and treatment of stroke patients. In the current study we have reviewed the published data from EU countries, Iceland, Norway, and Switzerland, and provide WHO estimates for stroke incidence and prevalence in these countries.Studies on stroke epidemiology published in peer-reviewed journals during the past 10 years were identified using Medline/PubMed searches, and reviewed using the structure of WHO's stroke component of the WHO InfoBase. WHO estimates for stroke incidence and prevalence for each country were calculated from routine mortality statistics. Rates from studies that met the ÔidealÕ criteria were compared with WHO's estimates.Forty-four incidence studies and 12 prevalence studies were identified. There were several methodological differences that hampered comparisons of data. WHO stroke estimates were in good agreement with results from ÔidealÕ stroke population studies. According to the WHO estimates the number of stroke events in these selected countries is likely to increase from 1.1 million per year in 2000 to more than 1.5 million per year in 2025 solely because of the demographic changes.Until better and more stroke studies are available, the WHO stroke estimates may provide the best data for understanding the stroke burden in countries where no stroke data currently exists. A standardized protocol for stroke surveillance is recommended. IntroductionRoutine mortality statistics indicate that there are considerable differences in stroke mortality between different European countries with several East European countries having high and increasing stroke mortality rates whilst low and decreasing rates are reported from most West European countries [1]. Projections for the European region suggest that the proportion of the population aged 65+, in which most stroke events occur, will increase from 20% in 2000 to 35% in 2050, and the median age will rise from 37.7 years in 2000 to 47.7 years in 2050 [2]. The projected population for Europe will decrease from 728 million in 2000 to 705 million in 2050, thus the dependency ratio will shift with fewer young people supporting an increasing proportion of elderly people. This will be a tremendous challenge for societies and health systems.Planning future need of health services and improved primary and secondary prevention of stroke require data on stroke occurrence. The present study reviews the available data on stroke from studies in Member States of the European Union, and three countries participating in the European Fair Trade Association (EFTA) Iceland, Norway, and Switzerland, published during the past 10 years using the stroke component of World Health Organization (WHO) InfoBase (Stroke Component of WHO NCD InfoBase). In addition, we present WHO estimates on stroke incidence, prevalence, and projections for these countries. Materials and methodsStudies on stroke epidemiology in European populations, published in peer-...

show abstract

Section: Stroke Incidence and Prevalence In Europementioning

confidence: 99%

Stroke incidence and prevalence in Europe: a review of available data

Truelsen

Piechowski-Jóźwiak

Bonita

et al. 2006

Euro J of Neurology

545

340

View full text Add to dashboard Cite

show abstract

“…However, the information on the death certificate is not always accurate 2 and not based on standardized criteria. Therefore, epidemiological studies with standardized diagnostic criteria are more useful to compare the incidence of CVD among countries.…”

Section: Cvd Mortality and Incidence In Asiamentioning

confidence: 99%

Epidemiology of Stroke and Coronary Artery Disease in Asia

Hata

Kiyohara

2013

Circ J

Self Cite

157

View full text Add to dashboard Cite

Stroke and coronary artery disease (CAD) are major causes of death throughout the world. As half of the world's population lives in Asian countries, prevention of stroke and CAD in Asia is crucial. According to the vital statistics, East Asian countries have a lower mortality rate for CAD than for stroke. In contrast, CAD is a more common cause of death than stroke in other Asian countries and Western countries. Hypertension, diabetes, hypercholesterolemia, and smoking are major risk factors for stroke and CAD in Asia as well as in Western countries. In an observational study in Japan, the stroke incidence decreased as a result of improvements in blood pressure control and reduction in the smoking rate over the past half century, whereas the CAD incidence did not show a clear secular change, probably because the benefits of blood pressure control and smoking cessation were negated by increasing prevalence of both glucose intolerance and hypercholesterolemia. Although Asian populations have lower serum cholesterol levels than Western populations, the prevalence of hypercholesterolemia has increased during the past half century in Asia. In addition, the smoking rate among Asian men is higher than for Western men. These results underscore that, in addition to blood pressure control, smoking cessation and the management of metabolic risk factors are very important for prevention of stroke and CAD in Asia. (Circ J 2013; 77: 1923 -1932

show abstract

“…It is known that vital statistics based on death certificates do not necessarily reflect the underlying cause of death. 41 Although the accuracy of death certificate diagnosis for HF has improved since the ICD-10 in 1995, 42 it is likely that some misclassification remains and could also be a source of bias. Third, misclassification of exposure time may have underestimated the true risk of death.…”

Section: Study Limitationsmentioning

confidence: 99%